Guidelines for the definitions of time-to-event endpoints in randomized clinical trials: Results of the DATECAN Project for Sarcomas and GISTs.
Carine A. Bellera
No relevant relationships to disclose
Monia Ouali
No relevant relationships to disclose
Nicolas Penel
No relevant relationships to disclose
Sylvie Bonvalot
No relevant relationships to disclose
Paolo Giovanni Casali
No relevant relationships to disclose
Martine Delannes
No relevant relationships to disclose
Ole Steen Nielsen
No relevant relationships to disclose
Simone Mathoulin-Pelissier
No relevant relationships to disclose